EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Receives Consensus Recommendation of “Buy” from Analysts
Shares of EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT – Get Free Report) have earned an average rating of “Buy” from the seven research firms that are currently covering the stock, Marketbeat reports. Seven analysts have rated the stock with a buy recommendation. The average 12 month target price among brokerages that have covered the stock in the […]
More Stories
Israel, Turkey Continue Dispute Over Syria After Airbase Strike
By Evgenia Filimianova Israel and Turkey have deepened their dispute over Syria after Israel defended its strike on a Syrian...
First Lady Unveils Racing Collaboration, $2 Million in ‘Fostering the Future’ Scholarships
By Travis Gillmore WASHINGTON—First Lady Melania Trump held her first public event in about two months at the White House...
US Unemployment Claims Unexpectedly Dropped Last Week
By Andrew Moran The number of Americans submitting applications for unemployment benefits unexpectedly declined last week for the first time...
A Tale of 2 Straits: Global Shippers Prefer Washington’s Version Over Tehran’s
By John Haughey With the Aug. 17 expiration of the 60-day memorandum of understanding between the United States and Iran,...
Karmelo Anthony Seeks Retrial in Texas Track Meet Stabbing Case
By Stacy Robinson Karmelo Anthony is asking a newly appointed Texas judge to grant him a retrial after he was...
UAE Halts All Iranian Trade After 2 Missiles Launched From Iranian Territory
By Jill McLaughlin The United Arab Emirates (UAE) halted all trade with Iran after officials determined two missiles detected earlier...